Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System-Reference-Cited by-同舟云学术

Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System

Published:2014-06-24 Issue:4 Volume:96 Page:477-481
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Wadelius M,Marshall S E,Islander G,Nordang L,Karawajczyk M,Yue Q-Y,Terreehorst I,Baranova E V,Hugosson S,Sköldefors K,Pirmohamed M,Maitland-van der Zee A-H,Alfirevic A,Hallberg P,Palmer C N A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers

2. Angiotensin-Converting Enzyme Inhibitors and Angioedema

3. Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information

4. Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes;Frontiers in Genetics;2022-07-18

2. Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema;Pharmacogenomics;2021-04

3. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema;Clinical Pharmacology & Therapeutics;2020-07-18

4. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment;The Pharmacogenomics Journal;2020-02-21

5. SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions;The Pharmacogenomics Journal;2020-01-17